Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hajduk

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Chemical Research in Toxicology|November 16, 2007
Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonanceJeffrey R Huth, Danying Song, Renaldo R Mendoza, et al.
Journal of Medicinal Chemistry|December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailabilityPhilip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.
Journal of Medicinal Chemistry|October 3, 1999
Novel inhibitors of Erm methyltransferases from NMR and parallel synthesisP J Hajduk, J Dinges, J M Schkeryantz, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Potent, selective inhibitors of protein tyrosine phosphatase 1BZhili Xin, Thorsten K Oost, Cele Abad-Zapatero, et al.
Journal of Medicinal Chemistry|December 22, 2000
Design of adenosine kinase inhibitors from the NMR-based screening of fragmentsP J Hajduk, A Gomtsyan, S Didomenico, et al.
Journal of Medicinal Chemistry|September 19, 2003
Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitorGang Liu, Zhili Xin, Zhonghua Pei, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Identification of a monoacid-based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1BZhili Xin, Gang Liu, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Structure-activity relationships of novel potent MurF inhibitorsYu Gui Gu, Alan S Florjancic, Richard F Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RSChaohong Sun, Danying Song, Rachel A Davis-Taber, et al.
Journal of the American Chemical Society|April 3, 2003
Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategyBruce G Szczepankiewicz, Gang Liu, Philip J Hajduk, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Chemical Research in Toxicology|November 16, 2007
Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonanceJeffrey R Huth, Danying Song, Renaldo R Mendoza, et al.
Journal of Medicinal Chemistry|December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailabilityPhilip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.
Journal of Medicinal Chemistry|October 3, 1999
Novel inhibitors of Erm methyltransferases from NMR and parallel synthesisP J Hajduk, J Dinges, J M Schkeryantz, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Potent, selective inhibitors of protein tyrosine phosphatase 1BZhili Xin, Thorsten K Oost, Cele Abad-Zapatero, et al.
Journal of Medicinal Chemistry|December 22, 2000
Design of adenosine kinase inhibitors from the NMR-based screening of fragmentsP J Hajduk, A Gomtsyan, S Didomenico, et al.
Journal of Medicinal Chemistry|September 19, 2003
Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitorGang Liu, Zhili Xin, Zhonghua Pei, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Identification of a monoacid-based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1BZhili Xin, Gang Liu, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Structure-activity relationships of novel potent MurF inhibitorsYu Gui Gu, Alan S Florjancic, Richard F Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RSChaohong Sun, Danying Song, Rachel A Davis-Taber, et al.
Journal of the American Chemical Society|April 3, 2003
Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategyBruce G Szczepankiewicz, Gang Liu, Philip J Hajduk, et al.
Pageof 8